These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 34702687

  • 1. Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol.
    Sánchez-Canteli M, Núñez-Batalla F, Martínez-González P, de Lucio-Delgado A, Antonio Villegas-Rubio J, Gómez-Martínez JR, Luis Llorente-Pendás J.
    An Pediatr (Engl Ed); 2021 Nov; 95(5):290-297. PubMed ID: 34702687
    [Abstract] [Full Text] [Related]

  • 2. [Ototoxicity in cancer survivors: experience and proposal of a surveillance protocol].
    Sánchez-Canteli M, Núñez-Batalla F, Martínez-González P, de Lucio-Delgado A, Villegas-Rubio JA, Gómez-Martínez JR, Llorente-Pendás JL.
    An Pediatr (Engl Ed); 2020 Sep 28. PubMed ID: 32998843
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal H, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O, PanCareLIFE consortium.
    Eur J Cancer; 2020 Oct 28; 138():212-224. PubMed ID: 32905960
    [Abstract] [Full Text] [Related]

  • 4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2014 Jul 01; (7):CD009219. PubMed ID: 24984156
    [Abstract] [Full Text] [Related]

  • 5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW, van den Berg H, van Dalen EC.
    Cochrane Database Syst Rev; 2012 May 16; (5):CD009219. PubMed ID: 22592737
    [Abstract] [Full Text] [Related]

  • 6. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    Fetoni AR, Brigato F, De Corso E, Lucidi D, Sergi B, Scarano E, Galli J, Ruggiero A.
    Eur Arch Otorhinolaryngol; 2022 Oct 16; 279(10):4677-4686. PubMed ID: 35024956
    [Abstract] [Full Text] [Related]

  • 7. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
    Clemens E, de Vries AC, Pluijm SF, Am Zehnhoff-Dinnesen A, Tissing WJ, Loonen JJ, van Dulmen-den Broeder E, Bresters D, Versluys B, Kremer LC, van der Pal HJ, van Grotel M, van den Heuvel-Eibrink MM, DCOG-LATER, The Netherlands.
    Eur J Cancer; 2016 Dec 16; 69():77-85. PubMed ID: 27821322
    [Abstract] [Full Text] [Related]

  • 8. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S, Del Valle Á, Chuang A, Becker A.
    Int J Pediatr Otorhinolaryngol; 2018 Aug 16; 111():174-179. PubMed ID: 29958605
    [Abstract] [Full Text] [Related]

  • 9. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ.
    Pediatr Blood Cancer; 2014 Nov 16; 61(11):2012-7. PubMed ID: 24976616
    [Abstract] [Full Text] [Related]

  • 10. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
    Fetoni AR, Ruggiero A, Lucidi D, De Corso E, Sergi B, Conti G, Paludetti G.
    Audiol Neurootol; 2016 Nov 16; 21(4):203-211. PubMed ID: 27286730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 16; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 14. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
    Waissbluth S, Peleva E, Daniel SJ.
    Eur Arch Otorhinolaryngol; 2017 Mar 16; 274(3):1187-1196. PubMed ID: 27245751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Phillips OR, Baguley DM, Pearson SE, Akeroyd MA.
    J Cancer Surviv; 2023 Feb 16; 17(1):40-58. PubMed ID: 36637633
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is Methotrexate Ototoxic? Investigating the Ototoxic Late Effects of Pediatric Cancer Treatment.
    Moore B, Sheets G, Doss J, Umrigar A, Norman M, Fang Z, Prasad P, Musso A, Clay S, Tsien F.
    Am J Audiol; 2023 Sep 06; 32(3):657-664. PubMed ID: 37532243
    [Abstract] [Full Text] [Related]

  • 20. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B, Knight K.
    Int J Audiol; 2018 Sep 06; 57(sup4):S34-S40. PubMed ID: 28737048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.